For example, if NREM sleep-promoting pathways (such as the melanin-concentrating hormone) that inhibit wake-promoting pathways are impaired early in HD, then this may result in abnormal transition dynamics without a change in the length of the sleep episode. This evidence concerns the gene PMCH and Huntington disease.